Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Keros Therapeutics (KROS) Receivables - Other (2019 - 2021)

Keros Therapeutics' Receivables - Other history spans 3 years, with the latest figure at $100000.0 for Q2 2021.

  • For Q2 2021, Receivables - Other changed N/A year-over-year to $100000.0; the TTM value through Jun 2021 reached $100000.0, changed N/A, while the annual FY2019 figure was $900000.0, N/A changed from the prior year.
  • Receivables - Other reached $100000.0 in Q2 2021 per KROS's latest filing, down from $805000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $900000.0 in Q4 2019 to a low of $100000.0 in Q2 2021.
  • Average Receivables - Other over 3 years is $601666.7, with a median of $805000.0 recorded in 2020.